West Pharmaceutical Services Inc

WST: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|DvLOCK|<$LOCK|<G&ggNv

West Pharmaceutical Earnings: Results Far Exceed Expectations; Guidance Revised Sharply Upward

West reported organic revenue growth of 15% to start the year and adjusted diluted earnings per share growth of 47% for the quarter. Guidance for 2026 was revised upward to 8% organic revenue growth and 18% adjusted diluted EPS growth at the midpoints. Shares rallied about 13% as of this writing.

Sponsor Center